Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 6, 2017
Treatment of elderly patients with acute myeloid leukemiaTomonori Nakazato
Transplantation Proceedings|June 8, 2020
The Prognostic Significance of Pretransplant Plasma Fibrinogen Levels in Autologous Hematopoietic Stem Cell TransplantationShinji Ogura, Tomonori Nakazato
International Journal of Oncology|February 1, 2014
Triptolide induces apoptotic cell death of multiple myeloma cells via transcriptional repression of Mcl-1Tomonori Nakazato, Morihiko Sagawa, Masahiro Kizaki
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
Green tea component, catechin, induces apoptosis of human malignant B cells via production of reactive oxygen speciesTomonori Nakazato, Keisuke Ito, Yasuo Ikeda, et al.
International Journal of Hematology|March 10, 2004
Transformation of myelodysplastic syndrome to acute lymphoblastic leukemia: a case report and review of the literatureNorihide Sato, Tomonori Nakazato, Masahiro Kizaki, et al.
International Journal of Oncology|May 10, 2007
A natural peptide, dolastatin 15, induces G2/M cell cycle arrest and apoptosis of human multiple myeloma cellsMasanori Sato, Morihiko Sagawa, Tomonori Nakazato, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 5, 2024
Disseminated Mycobacterium kansasii infection due to surgical site infection following allogeneic hematopoietic stem cell transplantation: A case report and literature reviewErika Sekiguchi, Shuhei Kurosawa, Yuki Iketani, et al.
Internal Medicine (Tokyo, Japan)|October 17, 2009
Refractory plasmablastic type myeloma with multiple extramedullary plasmacytomas and massive myelomatous effusion: remarkable response with a combination of thalidomide and dexamethasoneTomonori Nakazato, Kazuhito Suzuki, Ai Mihara, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 25, 2010
[Successful induction of complete cytogenetic response with low-dose imatinib mesylate in an accelerated phase chronic myelogenous leukemia patient who developed severe bone marrow aplasia following standard-dose imatinib mesylate therapy]Tomonori Nakazato, Kazuhito Suzuki, Ai Mihara, et al.
Hematology Reports|October 25, 2024
The Real-World Outcomes of Relapsed/Refractory Multiple Myeloma Treated with Elotuzumab, Pomalidomide, and DexamethasoneHitomi Nakayama, Yoshinobu Aisa, Chisako Ito, et al.
Pageof 9